Name: 글로벌 시장 동향
SKU: MD659
Availability: InStock

보고서 요약(국문)

보고서 개요
글로벌 수액 치료 시장은 2023년 435억 달러 규모에 달했으며, 2024년부터 2031년까지 연평균 6.8%의 성장률을 보이며 2031년에는 737억 달러에 이를 것으로 예상됩니다.
수액 치료(정맥 주사 요법)는 바늘이나 카테터를 통해 약물, 수액 또는 영양분을 환자의 혈류에 직접 투여하는 의료 시술입니다. 이 방법은 주로 다양한 질환에 대한 즉각적이고 효과적인 치료를 제공하는 데 사용됩니다.
수액 치료는 특히 삼키기 어려운 환자에게 경구 투약보다 안전한 대안이 될 수 있습니다. 또한 위산이 특정 약물의 효과를 저해하여 약효를 떨어뜨릴 수 있는 경우에도 유용합니다. 수액 치료는 정확한 용량 투여와 지속적인 약물 투여가 필요한 질환 관리에 매우 중요합니다. 약물을 지속적이고 정확하게 투여하는 능력은 다양한 건강 문제를 효과적으로 치료하는 데 필수적입니다.

시장 동향: 성장 동력
만성 질환 유병률 증가 및 기술 발전
전 세계 주입 치료 시장의 수요는 여러 요인에 의해 주도되고 있습니다. 주요 요인 중 하나는 만성 질환 유병률 증가와 기술 발전입니다. 당뇨병, 암, 심혈관 질환과 같은 만성 질환의 발병률 증가는 주입 치료 시장 성장을 크게 견인하고 있습니다. 이러한 질환들은 장기적인 관리와 정확한 약물 투여를 필요로 하기 때문에 주입 치료의 중요성이 더욱 커지고 있습니다.
세계보건기구(WHO)의 2024년 자료에 따르면, 심혈관 질환은 전 세계 사망 원인 1위이며 매년 약 1,790만 명의 사망자를 발생시킵니다. 주입 치료는 심부전과 같이 지속적인 약물 투여가 필수적인 질환 관리에 중요한 역할을 합니다.
특히 실시간 모니터링을 위해 전자 건강 기록(EHR)과 연동되는 스마트 주입 펌프 개발과 같은 주입 장치 혁신은 환자의 안전과 치료 효과를 크게 향상시키고 있습니다. 이러한 발전은 주입 치료의 환경을 변화시켜 더욱 효율적이고 사용자 친화적으로 만들어 시장 성장을 촉진할 것입니다. 또한, 만성 질환에 대한 혁신적인 치료법 도입과 첨단 소프트웨어 출시와 같은 업계의 기술 발전을 주도하는 주요 기업들이 이 시장 성장을 견인하고 있습니다. 예를 들어, 2024년 2월 영국 국민보건서비스(NHS)는 진행성 파킨슨병 치료를 위한 새로운 약물인 포스레보도파-포스카르비도파(일명 프로두오도파)를 출시했습니다. 이 혁신적인 치료법은 기존 경구 약물로 증상이 충분히 조절되지 않는 환자를 위해 고안되었습니다. 이 치료법은 피부 아래에 착용하는 소형 펌프를 통해 약물을 지속적으로 공급하는 휴대용 주입 시스템을 사용하여 24시간 증상 관리가 가능합니다.
마찬가지로, 2023년 6월 B. Braun Medical Inc.는 의료기관 내 주입 펌프 관리를 강화하기 위한 최신 주입 관리 소프트웨어인 DoseTrac Enterprise Infusion Management Software를 공개했습니다. 이 첨단 소프트웨어는 실시간 모니터링과 사후 보고 기능을 결합하여 의료기관이 주입 펌프 운영 현황과 관련 데이터를 더욱 심층적으로 파악할 수 있도록 지원합니다.

제약 요인
고비용 첨단 기술, 기기의 위험성 및 복잡성, 규제 및 상환 문제 등이 시장 성장을 저해할 것으로 예상됩니다.
시장 세분화 분석
전 세계 주입 치료 시장은 제품 유형, 투여 경로, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
주입 펌프 부문은 전 세계 주입 치료 시장의 약 52.1%를 차지했습니다.
주입 펌프 부문은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 정확하고 효율적인 약물 전달 시스템에 대한 수요 증가로 주입 펌프 사용이 늘어나고 있습니다. 이 장치는 환자에게 정해진 용량으로 수액, 약물 또는 영양분을 투여하도록 특별히 설계되어 다양한 의료 분야에서 매우 중요합니다.
주입 펌프 부문은 환자 안전과 치료 효과를 크게 향상시키는 지속적인 기술 발전이 특징입니다. 가장 주목할 만한 혁신 중 하나는 전자 건강 기록(EHR)과 원활하게 통합되어 환자 데이터를 실시간으로 모니터링할 수 있는 스마트 주입 펌프의 개발입니다.

전자건강기록(EHR)과 통합된 스마트 주입 펌프는 투약 오류 위험을 최소화하여 환자 안전을 크게 향상시킵니다. 이 기술은 EHR에서 주입 펌프로 투약 처방을 자동으로 전송하여 수동 프로그래밍의 필요성을 없애고 인적 오류 발생 가능성을 줄입니다.
또한, 업계 주요 업체들의 신제품 출시와 주입 펌프 분야의 핵심 개발이 시장 성장을 견인하고 있습니다. 예를 들어, 2023년 2월 Mindray는 BeneFusion i 시리즈와 u 시리즈 주입 시스템을 출시하여 주입 기술의 중요한 발전을 이루었습니다. 이 시스템은 높은 정밀도, 맞춤형 적응성, 사용자 친화적인 인터페이스를 강조하여 다양한 임상 환경에서 투약 안전성을 향상시킵니다. 이러한 개발은 단순한 기계 장치에서 투약 오류를 최소화하고 환자 치료 결과를 개선하도록 설계된 정교한 시스템으로 발전해 온 스마트 주입 펌프의 도입 추세와 일맥상통합니다.

마찬가지로, 2023년 4월, Eitan Medical은 급성기 이후 치료 및 특수 주입 치료를 향상시키도록 설계된 최첨단 연결형 이동식 주입 펌프인 Avoset 주입 시스템을 출시했습니다. 이 혁신적인 시스템은 컴팩트한 디자인과 첨단 기술을 통해 환자 안전과 사용자 경험을 개선하는 데 중점을 두고 있습니다.
시장 지역 분석
북미는 전 세계 주입 치료 시장 점유율의 약 44.6%를 차지했습니다.
북미 지역은 암, 당뇨병, 심혈관 질환과 같은 만성 질환의 발병률 증가로 인해 주입 치료에 대한 수요가 크게 증가함에 따라 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
미국 암 협회에 따르면, 2021년 미국에서는 약 190만 건의 새로운 암 환자가 진단되었습니다. 암 진단을 받은 많은 환자는 화학 요법 및 기타 보조 치료와 같은 치료를 위해 주입 치료가 필요하며, 이는 관련 제품 및 서비스에 대한 수요 증가로 이어집니다.

마찬가지로 미국병원협회(American Hospital Association)는 미국 인구의 거의 절반에 해당하는 약 1억 3,300만 명이 고혈압, 심장병, 관절염과 같은 만성 질환을 하나 이상 앓고 있다고 밝혔습니다. 이 수치는 2030년까지 약 1억 7,000만 명으로 증가할 것으로 예상되며, 이는 만성 질환이 미국 의료 시스템에 미치는 부담이 점점 커지고 있음을 보여줍니다.
또한, 이 지역에서는 주요 업체들의 존재, 잘 발달된 의료 인프라, 기술 발전, 정부의 우호적인 의료비 상환 정책, 가정 의료 서비스에 대한 수요 증가, 신제품 출시 및 승인 등이 시장 성장을 견인할 것으로 예상됩니다.
예를 들어, 2024년 4월 캐나다에서 맥켄지 헬스(Mackenzie Health)가 BD 알라리스(Alaris) EMR 상호운용성 시스템을 출시한 것은 정맥 주사(IV) 약물 관리 분야에서 중요한 진전입니다. 이 혁신적인 기술은 IV 주입 펌프와 환자의 전자 의료 기록(EMR) 간의 양방향 통신을 가능하게 하여 주입 과정을 간소화하고 환자의 안전을 향상시킵니다.

또한, 2024년 4월, Baxter International Inc.는 Dose IQ 안전 소프트웨어가 탑재된 Novum IQ 대용량 주입 펌프(LVP)에 대해 FDA 510(k) 승인을 받았습니다. 이미 주사기 주입 펌프(SYR)를 포함하고 있는 Novum IQ 주입 플랫폼에 이 기능이 추가됨으로써 의료진은 다양한 환자 치료 환경에서 통합 시스템을 활용할 수 있게 되었습니다. Novum IQ 플랫폼은 LVP와 SYR 펌프를 통합하여 사용자 경험을 향상시키고, 임상의의 중요하지 않은 작업에 대한 부담을 줄여줍니다. 이러한 통합은 간소화된 교육 과정을 촉진하고 여러 펌프 시스템을 관리하는 데 따른 인지 부하를 감소시킵니다.
시장 세분화
제품 유형별
주입 펌프
정맥 주사 세트
정맥 카테터
무바늘 커넥터
정맥 영상 장치
투여 경로별
근육 주사
피하 주사
경막외 주사
적용 분야별
항생제 및 바이러스 치료
강심제 치료
항응고제 치료
항암 화학 요법
영양 요법
혈액 성분
기타
최종 사용자별
병원 및 전문 클리닉
외래 수술 센터
가정 간호
지역별
북미
미국
캐나다
멕시코
유럽
독일
영국
프랑스
스페인
이탈리아
기타 유럽
남미
브라질
아르헨티나
기타 남미
아시아 태평양
중국
인도
일본
한국
기타 아시아 태평양
중동 및 아프리카
시장 경쟁 시장 현황
주입 치료 시장의 주요 글로벌 업체로는 B. Braun Melsungen AG, ICU Medical, Inc., Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Becton, Dickinson and Company, Nipro Corporation, Mindray Medical India Pvt. Ltd., Moog Inc., Teleflex Incorporated 등이 있습니다.
주요 개발 사항
2024년 1월, AbbVie는 유럽 연합에서 진행성 파킨슨병 치료를 위한 지속적 피하 주입 요법인 Produodopa(포스레보도파/포스카르비도파)를 출시했습니다. Produodopa는 EU에서 해당 적응증으로 승인된 최초이자 유일한 24시간 레보도파 기반 피하 주입 요법입니다.
2023년 6월, Eitan Medical은 가정 및 특수 주입 요구에 맞춘 새로운 클라우드 기반 주입 관리 시스템인 Eitan Insights를 출시했습니다. 이 혁신적인 플랫폼은 Eitan Medical의 주입 시스템과 연결되며, 여기에는 범용 플러그 앤 플레이 방식의 셀룰러 액세서리인 Sapphire Connect를 탑재한 Sapphire 펌프와 AvosetGo 앱으로 보완되는 Avoset 펌프가 포함됩니다.
보고서 구매 이유:
제품 유형, 투여 경로, 적용 분야, 최종 사용자 및 지역별 글로벌 주입 치료 시장 세분화를 시각화하고 주요 상업 자산 및 업체들을 파악하기 위함입니다.
트렌드 분석 및 공동 개발을 통해 사업 기회를 식별할 수 있습니다.
모든 세그먼트를 포함한 주입 치료 시장의 다양한 데이터 포인트가 담긴 Excel 데이터 시트가 제공됩니다.
PDF 보고서는 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석 결과를 담고 있습니다.
모든 주요 업체들의 핵심 제품을 포함하는 제품 매핑 정보가 Excel 파일로 제공됩니다.

글로벌 주입 치료 시장 보고서는 약 70개의 표, 68개의 그림, 그리고 183페이지 분량으로 구성될 예정입니다.
대상 고객 (2024년 기준)
제조업체/구매자
산업 투자자/투자 은행가
연구 전문가
신흥 기업

보고서 요약(영어 원문)

Report Overview
The Global Infusion Therapy Market reached US$ 43.5 billion in 2023 and is expected to reach US$ 73.7 billion by 2031 growing with a CAGR of 6.8% during the forecast period 2024-2031.
Infusion therapy, also known as intravenous (IV) therapy, is a medical procedure that involves delivering medications, fluids, or nutrients directly into a patient's bloodstream through a needle or catheter. This method is primarily used to provide immediate and effective treatment for various medical conditions.
Infusion therapy serves as a safer alternative to oral medication, particularly for patients who have difficulty swallowing. It is also beneficial in situations where stomach acids could compromise the effectiveness of certain medications, rendering them less effective. Infusion therapy is crucial for managing medical conditions that necessitate precise dosing and uninterrupted medication administration. The ability to deliver medications continuously and accurately is vital for effectively treating various health issues.
Market Dynamics: Drivers
Rising prevalence of chronic diseases and technological advancements
The demand for the global infusion therapy market is driven by multiple factors. One of the primary factors is the rising prevalence of chronic diseases and technological advancements. The rising incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases significantly drives the infusion therapy market. These diseases often require long-term management and precise medication delivery, which makes infusion therapies increasingly essential.
According to the World Health Organization (WHO) data in 2024, indicates that cardiovascular diseases are the leading cause of death worldwide, responsible for approximately 17.9 million fatalities each year. Infusion therapy plays a vital role in managing conditions like heart failure, where continuous medication delivery is essential for achieving optimal patient outcomes.
Innovations in infusion devices, particularly the development of smart infusion pumps that integrate with electronic health records (EHRs) for real-time monitoring, are significantly enhancing patient safety and treatment efficacy. These advancements are transforming the landscape of infusion therapy, making it more efficient and user-friendly, which would propel market growth.
Moreover, key players in the industry's technological advancements such as the introduction of innovative treatments for chronic diseases and launching advanced software propel this market growth. For instance, in February 2024, the NHS launched a new treatment for advanced Parkinson's disease known as foslevodopa-foscarbidopa, also referred to as Produodopa. This innovative therapy is designed for patients whose symptoms are not adequately managed by traditional oral medications. It involves a portable, wearable infusion system that continuously delivers medication through a small pump worn under the skin, allowing for 24-hour symptom management.
Similarly, in June 2023, B. Braun Medical Inc. unveiled its latest infusion management software, DoseTrac Enterprise Infusion Management Software, aimed at enhancing the management of infusion pumps within healthcare organizations. This advanced software provides a combination of real-time monitoring and retrospective reporting capabilities, allowing organizations to gain deeper insights into their infusion pump fleet and the associated data.
Restraints
Factors such as the high cost of advanced technologies, risk & complexity of devices, and regulatory & reimbursement challenges are expected to hamper the market.
Market Segment Analysis
The global infusion therapy market is segmented based on product type, route of administration, application, end-user, and region.
The infusion pumps segment accounted for approximately 52.1% of the global infusion therapy market share
The infusion pumps segment is expected to hold the largest market share over the forecast period. The growing need for accurate and efficient medication delivery systems has led to a rise in the use of infusion pumps. These devices are specifically designed to administer fluids, medications, or nutrients to patients in regulated doses, making them crucial for a wide range of medical applications.
The infusion pumps segment is marked by ongoing technological advancements that significantly enhance patient safety and treatment effectiveness. One of the most notable innovations is the development of smart infusion pumps, which integrate seamlessly with electronic health records (EHRs) to facilitate real-time monitoring of patient data.
Smart infusion pumps with electronic health record (EHR) integration offer a significant improvement in patient safety by minimizing the risk of medication administration errors. This technology allows for the automatic transmission of medication orders directly from the EHR to the infusion pump, eliminating the need for manual programming and reducing the potential for human error.
Moreover, key players in the industry product launches and key developments in the infusion pumps are driving this segment growth in the market. For instance, in February 2023, Mindray launched the BeneFusion i Series and u Series infusion systems marking a significant advancement in infusion technology, emphasizing high precision, adaptive customization, and user-friendly interfaces to enhance medication safety across various clinical settings. This development aligns with the growing trend of adopting smart infusion pumps, which have evolved from basic mechanical devices to sophisticated systems designed to minimize medication errors and improve patient outcomes.
Similarly, in April 2023, Eitan Medical introduced the Avoset Infusion System, a cutting-edge connected ambulatory infusion pump designed to enhance post-acute care and specialty infusion therapy. This innovative system focuses on improving patient safety and user experience through its compact design and advanced technology.
Market Geographical Analysis
North America accounted for approximately 44.6% of the global infusion therapy market share
North America region is expected to hold the largest market share over the forecast period owing to the increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions significantly driving the demand for infusion therapy in North America.
According to the American Cancer Society, around 1.9 million new cancer cases were diagnosed in the United States in 2021. Many individuals diagnosed with cancer require infusion therapy for treatments such as chemotherapy and other supportive care, which leads to an increased demand for related products and services.
Similarly, American Hospital Association, stated that around 133 million people in the United States, which is nearly half the population, suffer from at least one chronic condition, such as hypertension, heart disease, or arthritis. This number is expected to rise to approximately 170 million by the year 2030, underscoring the increasing burden that chronic diseases place on the healthcare system in the country.
Moreover, in this region, a major number of key player's presence, well-advanced healthcare infrastructure, technological advancements, government favorable reimbursement policies, growing demand for home healthcare services, product launches, and approvals would drive this market growth.
For instance, in April 2024, in Canada, Mackenzie Health's launch of the BD Alaris EMR Interoperability system represents a significant advancement in intravenous (IV) medication management. This innovative technology enables two-way communication between IV infusion pumps and the patient's electronic medical record (EMR), streamlining the infusion process and enhancing patient safety.
Also, in April 2024, Baxter International Inc. received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) equipped with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which already includes a syringe infusion pump (SYR), allows healthcare providers to utilize a unified system across various patient care environments. The Novum IQ platform enhances the user experience by integrating the LVP and SYR pumps, thereby alleviating the workload of non-critical tasks for clinicians. This integration facilitates a streamlined training process and reduces the cognitive load associated with managing multiple pump systems.
Market Segmentation
By Product Type
Infusion Pumps
Intravenous Sets
IV Cannulas
Needleless Connectors
Vein Imaging Devices
By Route of Administration
Intramuscular
Subcutaneous
Epidural
By Application
Antibiotic & Viral
Inotropic Therapy
Anti-coagulation
Chemotherapy
Nutritional Therapy
Blood Component
Others
By End-User
Hospitals & Specialty Clinics
Ambulatory Surgery Centers
Homecare Settings
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
South America
Brazil
Argentina
The rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the infusion therapy market include B. Braun Melsungen AG, ICU Medical, Inc., Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Becton, Dickinson and Company, Nipro Corporation, Mindray Medical India Pvt. Ltd., Moog Inc., and Teleflex Incorporated among others.
Key Developments
In January 2024, AbbVie launched Produodopa (foslevodopa/foscarbidopa), a continuous subcutaneous infusion therapy, for the treatment of advanced Parkinson's disease in the European Union. Produodopa is the first and only 24-hour levodopa-based subcutaneous infusion therapy approved for this indication in the EU.
In June 2023, Eitan Medical introduced Eitan Insights, a new cloud-based infusion management system tailored for home and specialty infusion needs. This innovative platform connects with Eitan Medical's infusion systems, including the Sapphire pump, which now features a universal plug-and-play cellular accessory called Sapphire Connect, and the Avoset pump, complemented by the AvosetGo app.
Why Purchase the Report?
To visualize the global infusion therapy market segmentation based on product type, route of administration, application, end-user, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the infusion therapy market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.
The global infusion therapy market report would provide approximately 70 tables, 68 figures, and 183 pages
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Route of Administration
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Chronic Diseases and Technological Advancements
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Cost of Advanced Technologies
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Infusion Pumps *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Intravenous Sets
6.4. IV Cannulas
6.5. Needleless Connectors
6.6. Vein Imaging Devices
7. By Route of Administration
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
7.1.2. Market Attractiveness Index, By Route of Administration
7.2. Intramuscular *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Subcutaneous
7.4. Epidural
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Distribution Channels
8.2. Antibiotic & Viral *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Inotropic Therapy
8.4. Anti-coagulation
8.5. Chemotherapy
8.6. Nutritional Therapy
8.7. Blood Component
8.8. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals & Specialty Clinics *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgery Centers
9.4. Homecare Settings
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Spain
10.3.7.5. Italy
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.9. Brazil
10.4.10. Argentina
10.4.11. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. B. Braun Melsungen AG*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. ICU Medical, Inc.
12.3. Baxter International Inc.
12.4. Fresenius Kabi AG
12.5. Terumo Corporation
12.6. Becton, Dickinson and Company
12.7. Nipro Corporation
12.8. Mindray Medical India Pvt. Ltd.
12.9. Moog Inc.
12.10. Teleflex Incorporated (*LIST NOT EXHAUSTIVE)
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

B. Braun Melsungen AG, 4.	Key Developments, ICU Medical, Inc., Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Becton, Dickinson and Company, Nipro Corporation, Mindray Medical India Pvt. Ltd., Moog Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Infusion Therapy Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Infusion Therapy Market Value, By Route of Administration, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Infusion Therapy Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Infusion Therapy Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Infusion Therapy Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Infusion Therapy Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Infusion Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 8 Global Infusion Therapy Market Value, By Route of Administration, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Infusion Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 10 Global Infusion Therapy Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 11 Global Infusion Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global Infusion Therapy Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 13 Global Infusion Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 14 Global Infusion Therapy Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global Infusion Therapy Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Infusion Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 17 North America Infusion Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 18 North America Infusion Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America Infusion Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 North America Infusion Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Asia-Pacific Infusion Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 Asia-Pacific Infusion Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 23 Asia-Pacific Infusion Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 24 Asia-Pacific Infusion Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Infusion Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Infusion Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 27 Europe Infusion Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 28 Europe Infusion Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe Infusion Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 30 Europe Infusion Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 31 South America Infusion Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 32 South America Infusion Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 33 South America Infusion Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 34 South America Infusion Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 35 South America Infusion Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East and Africa Infusion Therapy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 37 Middle East and Africa Infusion Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 38 Middle East and Africa Infusion Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East and Africa Infusion Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 40 Middle East and Africa Infusion Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 41 B. Braun Melsungen AG: Overview

Table 42 B. Braun Melsungen AG: Product Portfolio

Table 43 B. Braun Melsungen AG: Key Developments

Table 44 ICU Medical, Inc.: Overview

Table 45 ICU Medical, Inc.: Product Portfolio

Table 46 ICU Medical, Inc.: Key Developments

Table 47 Baxter International Inc.: Overview

Table 48 Baxter International Inc.: Product Portfolio

Table 49 Baxter International Inc.: Key Developments

Table 50 Fresenius Kabi AG: Overview

Table 51 Fresenius Kabi AG: Product Portfolio

Table 52 Fresenius Kabi AG: Key Developments

Table 53 Terumo Corporation: Overview

Table 54 Terumo Corporation: Product Portfolio

Table 55 Terumo Corporation: Key Developments

Table 56 Becton, Dickinson and Company: Overview

Table 57 Becton, Dickinson and Company: Product Portfolio

Table 58 Becton, Dickinson and Company: Key Developments

Table 59 Nipro Corporation: Overview

Table 60 Nipro Corporation: Product Portfolio

Table 61 Nipro Corporation: Key Developments

Table 62 Mindray Medical India Pvt. Ltd.: Overview

Table 63 Mindray Medical India Pvt. Ltd.: Product Portfolio

Table 64 Mindray Medical India Pvt. Ltd.: Key Developments

Table 65 Moog Inc.: Overview

Table 66 Moog Inc.: Product Portfolio

Table 67 Moog Inc.: Key Developments

Table 68 Teleflex Incorporated: Overview

Table 69 Teleflex Incorporated: Product Portfolio

Table 70 Teleflex Incorporated: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 2 Global Infusion Therapy Market Share, By Product Type, 2023 & 2031 (%)

Figure 3 Global Infusion Therapy Market Share, By Route of Administration, 2023 & 2031 (%)

Figure 4 Global Infusion Therapy Market Share, By Application, 2023 & 2031 (%)

Figure 5 Global Infusion Therapy Market Share, By End-User, 2023 & 2031 (%)

Figure 6 Global Infusion Therapy Market Share, By Region, 2023 & 2031 (%)

Figure 7 Global Infusion Therapy Market Y-o-Y Growth, By Product Type, 2023-2031 (%)

Figure 8 Infusion Pumps Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 9 Intravenous Sets Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 10 IV Cannulas Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 11 Needleless Connectors Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 12 Vein Imaging Devices Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 13 Global Infusion Therapy Market Y-o-Y Growth, By Route of Administration, 2023-2031 (%)

Figure 14 Intramuscular Route of Administration in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 15 Subcutaneous Route of Administration in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 16 Epidural Route of Administration in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 17 Global Infusion Therapy Market Y-o-Y Growth, By Application, 2023-2031 (%)

Figure 18 Antibiotic & Viral Application in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 19 Inotropic Therapy Application in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 20 Anti-coagulation Application in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 21 Chemotherapy Application in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 22 Nutritional Therapy Application in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 23 Blood Component Application in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 24 Others Application in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 25 Global Infusion Therapy Market Y-o-Y Growth, By End-User, 2023-2031 (%)

Figure 26 Hospitals & Specialty Clinics End-User in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 27 Ambulatory Surgery Centers End-User in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 28 Homecare Settings End-User in Global Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 29 Global Infusion Therapy Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 30 North America Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 31 North America Infusion Therapy Market Share, By Product Type, 2023 & 2031 (%)

Figure 32 North America Infusion Therapy Market Share, By Route of Administration, 2023 & 2031 (%)

Figure 33 North America Infusion Therapy Market Share, By Application, 2023 & 2031 (%)

Figure 34 North America Infusion Therapy Market Share, By End-User, 2023 & 2031 (%)

Figure 35 North America Infusion Therapy Market Share, By Country, 2023 & 2031 (%)

Figure 36 Asia-Pacific Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 37 Asia-Pacific Infusion Therapy Market Share, By Product Type, 2023 & 2031 (%)

Figure 38 Asia-Pacific Infusion Therapy Market Share, By Route of Administration, 2023 & 2031 (%)

Figure 39 Asia-Pacific Infusion Therapy Market Share, By Application, 2023 & 2031 (%)

Figure 40 Asia-Pacific Infusion Therapy Market Share, By End-User, 2023 & 2031 (%)

Figure 41 Asia-Pacific Infusion Therapy Market Share, By Country, 2023 & 2031 (%)

Figure 42 Europe Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 43 Europe Infusion Therapy Market Share, By Product Type, 2023 & 2031 (%)

Figure 44 Europe Infusion Therapy Market Share, By Route of Administration, 2023 & 2031 (%)

Figure 45 Europe Infusion Therapy Market Share, By Application, 2023 & 2031 (%)

Figure 46 Europe Infusion Therapy Market Share, By End-User, 2023 & 2031 (%)

Figure 47 Europe Infusion Therapy Market Share, By Country, 2023 & 2031 (%)

Figure 48 South America Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 49 South America Infusion Therapy Market Share, By Product Type, 2023 & 2031 (%)

Figure 50 South America Infusion Therapy Market Share, By Route of Administration, 2023 & 2031 (%)

Figure 51 South America Infusion Therapy Market Share, By Application, 2023 & 2031 (%)

Figure 52 South America Infusion Therapy Market Share, By End-User, 2023 & 2031 (%)

Figure 53 South America Infusion Therapy Market Share, By Country, 2023 & 2031 (%)

Figure 54 Middle East and Africa Infusion Therapy Market Value, 2022-2031 (US$ Million)

Figure 55 Middle East and Africa Infusion Therapy Market Share, By Product Type, 2023 & 2031 (%)

Figure 56 Middle East and Africa Infusion Therapy Market Share, By Route of Administration, 2023 & 2031 (%)

Figure 57 Middle East and Africa Infusion Therapy Market Share, By Application, 2023 & 2031 (%)

Figure 58 Middle East and Africa Infusion Therapy Market Share, By End-User, 2023 & 2031 (%)

Figure 59 B. Braun Melsungen AG: Financials

Figure 60 ICU Medical, Inc.: Financials

Figure 61 Baxter International Inc.: Financials

Figure 62 Fresenius Kabi AG: Financials

Figure 63 Terumo Corporation: Financials

Figure 64 Becton, Dickinson and Company: Financials

Figure 65 Nipro Corporation: Financials

Figure 66 Mindray Medical India Pvt. Ltd.: Financials

Figure 67 Moog Inc.: Financials

Figure 68 Teleflex Incorporated: Financials

글로벌 주입 치료 시장 – 2024-2031

Global Infusion Therapy Market - 2024-2031